Chronic HBV infections remains a major public health issue globally despite the advent of vaccine and antiviral therapy. This talk reviews what we know so far about chronic HBV in the context of HIV infected patients and what remains to be done.
The Oregon AIDS Education and Training Center, in collaboration with the Oregon Health Authority, is hosting a two-day training event for individuals in a professional role to support those at risk of or living with HIV/AIDS in their community. This includes clinicians, nurses, pharmacists, case managers, care coordinators and community health workers. Applications for CE credits (physicians, pharmacists, nurses, and social workers) will be filed.
Training topics include:
What Makes This Conference Unique
This inter-professional training opportunity will have both a clinical track and a patient navigation track with strategically overlapping general sessions to encourage systematic approaches to implementation of key strategies presented throughout the conference.
Wednesday, October 11, 2017 from 10:00 AM to 5:00 PM
Thursday, October 12, 2017 from 9:00 AM - 3:00 PM
Meals will be provided - Registration is required.
Fees: FREE to Oregon providers in a professional role to support people at risk of or living with HIV. Attendees from outside of Oregon are asked to pay a $45 registration fee to cover food and CE costs.
Location: Sheraton Portland Airport Hotel, 8235 NE Airport Way, Portland, OR 97220
HIV disproportionately burdens transgender people, particularly women of color. The speaker will discuss the epidemiology of HIV and sexually transmitted infections (STIs) and why this population is more at risk. He will also review current research on HIV prevention, including PrEP, among transgender women.
Kevin Ard, MD, MPH is Medical Director, National LGBT Health Education Center, Fenway Institute and Faculty, Infectious Disease Division, Massachusetts General Hospital.
Pre-registration is not required if attending the one hour in-person session at: Harborview Medical Center's Research and Training Building, Auditorium, 300 9th Avenue, Seattle, WA 98104. Please click on "register" to attend the live webinar.
Efforts to control HIV/AIDS now depend almost entirely on biomedical interventions to reduce infectiousness through antiretroviral drugs and to prevent acquisition among uninfected individuals via a number of interventions like PrEP. These interventions will be reviewed in the context of implementation, both successes and limitations.
Thomas Quinn, MD, MSc is Director of Johns Hopkins Center for Global Health, Professor of Medicine and Pathology in the Johns Hopkins University School of Medicine, Associate Director for International Research, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.
ACC is always free! To join the live webinar, register here. Pre-registration not required if attending the one hour in-person session at: Harborview Medical Center's Research and Training Bldg, Auditorium at 300 9th Avenue, Seattle, WA 98104.
What is this lecture series?
Typically held on the third Tuesday of every month, the AIDS Clinical Conference (ACC) features local and national experts discussing a broad range of topics related to the clinical care of persons living with HIV. 1.2 CNE contact hours are available for eligible participants. To sign up for the ACC mailing list: register here